
Bloomberg Businessweek
Bloomberg Markets: Gilead to Buy Kite for $11.9 Billion
10 min•28 augusti 2017
Om avsnittet
(Bloomberg) -- Bloomberg Markets with Carol Massar and Cory Johnson. GUEST: Asthika Goonewardene Senior Analyst:Biotech Bloomberg Intelligence Discussing Gilead Sciences Inc. agreed to buy Kite Pharma Inc. for about $11.9 billion, making one of its biggest deals ever to expand beyond its eroding hepatitis C drug franchise.
See omnystudio.com/listener for privacy information.
Fler avsnitt
Visa alla avsnitt av Bloomberg BusinessweekBloomberg Businessweek med Bloomberg finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.